Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 6, 2015

View Archived Issues

Isomerase Therapeutics discloses novel polyketide FKBP1A inhibitors

New preclinical data on JNK inhibitors for the treatment of neurological diseases

First evidence for SESN3 gene as a modulator of proconvulsant gene network

Ligand signs license agreement with Sermonix for lasofoxifene

Trevena presents an innovative composite endpoint for BLAST-AHF trial

WaVe Life Sciences closes Series A financing

Moderna Therapeutics and Institut Pasteur form infectious disease research collaboration

Allegro's phase II study of Luminate for DME supported by grant

Genmab reports data from phase II study of daratumumab in refractory multiple myeloma

Mast Therapeutics begins phase IIa studies of AIR-001 in heart failure

Ironwood Pharmaceuticals reports data from exploratory phase IIa trial of IW-3718 in GERD

Proteostasis Therapeutics selects PTI-130 as a development candidate for CF

OncoMed begins dosing in phase II study of demcizumab in NSCLC

Motif Bio seeks to raise funds to support pipeline

Lundbeck reviews fourth quarter 2014

BrainStorm reports positive recommendation in ongoing phase II trial of NurOwn

Ayoxxa and SERI collaborate on protein multiplexing technology platform for ophthalmology

FDA clears Sangamo to begin phase I/II study of its ZFP Therapeutic for beta-thalassemia

Albireo initiates phase II trial of A-4250 in patients with primary biliary cirrhosis

Mylan to acquire female reproductive health care businesses from Famy Care

Bayer Schering Pharma reports dual sGC activators/PDE5 inhibitors

The Medicines Company completes acquisition of Annovation Biopharma

Dehydroleucodine derivatives patented by U.S. and Ecuador Universities

Gilead presents new anti-HIV compounds

Takeda discloses new MCHR-1 antagonists

Revolution Medicines launched to discover optimized analogues of natural products

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...